{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-060661","form_type":"8-K","ticker":"CLRB","cik":"0001279704","company_name":"Cellectar Biosciences, Inc.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.824250+00:00","generated_at":"2026-05-19T02:34:12.675872+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cellectar Biosciences announces 1-for-30 reverse stock split; effective June 24, 2025","bullets":["Approved by stockholders at June 13, 2025 annual meeting; board set final ratio as 1-for-30.","Reduces outstanding shares from ~54.4M to ~1.8M; effective at 12:01 a.m. ET on June 24.","Fractional shareholders will receive cash in lieu; authorized shares and par value unchanged.","Ticker remains CLRB on Nasdaq; new CUSIP number 15117F880 begins June 24.","Outstanding options, warrants, and preferred stock conversion ratios adjust proportionately."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-060661","json":"https://secwatch.observer/filing/0001104659-25-060661.json","markdown":"https://secwatch.observer/filing/0001104659-25-060661.md","text":"https://secwatch.observer/filing/0001104659-25-060661.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925060661/0001104659-25-060661-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925060661/tm2518341d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T02:34:12.675872+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}